CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
Irvine, CA – April 29, 2020 – - Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. patent valid until 2036 covering its unique, non-cooled, diffuser-type laser ablation applicator. The applicators are a disposable accessory for use with the company’s TRANBERG[®]|Thermal Therapy System , which provides high precision, MRI-guided, minimally invasive focal laser ablation treatments for challenging soft tissue conditions and cancer